Terry L. Murdock, Chief Operating Officer at G1 Therapeutics, Inc. (GTHX), sold 3,740 shares at $2.94 ($12K) on 2024-01-04, disclosed to the SEC on 2024-01-08.
Seasonal sale ($12k) by Chief Operating Officer — this insider has traded GTHX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.12 | 758 | $2K | 20.5% |
| 2 | $3.12 | 2,261 | $7K | 61.1% |
| 3 | $2.94 | 721 | $2K | 18.4% |
| Total | $3.09 avg | 3,740 | $12K | 100% |
| Filing → |
| GTHX | SELL | 2023-07-07 | $3K | — | Filing → |
| GTHX | SELL | 2023-01-05 | $13K | — | Filing → |
| GTHX | SELL | 2022-07-06 | $3K | — | Filing → |